Edition:
India

Alterity Therapeutics Ltd (ATHE.OQ)

ATHE.OQ on NASDAQ Stock Exchange Capital Market

1.20USD
20 Sep 2019
Change (% chg)

$0.09 (+8.64%)
Prev Close
$1.10
Open
$1.16
Day's High
$1.20
Day's Low
$1.16
Volume
1,491
Avg. Vol
4,117
52-wk High
$2.72
52-wk Low
$0.91

Latest Key Developments (Source: Significant Developments)

Prana Receives Orphan Drug Designation From FDA For Treatment Of Multiple System Atrophy
Thursday, 31 Jan 2019 

Jan 31 (Reuters) - Prana Biotechnology Ltd ::PRANA RECEIVES FIRST ORPHAN DRUG DESIGNATION FROM THE FDA FOR THE TREATMENT OF MULTIPLE SYSTEM ATROPHY.PRANA BIOTECHNOLOGY LTD - PRANA IS CONDUCTING A PHASE 1 CLINICAL TRIAL OF PBT434 AND EXPECTS IT TO BE COMPLETED THIS YEAR.  Full Article

Prana Biotechnology Says US Food And Drug Administration Granted Designation For Lead Molecule PBT434
Thursday, 31 Jan 2019 

Jan 31 (Reuters) - Prana Biotechnology Ltd ::PRANA BIOTECHNOLOGY-US FOOD AND DRUG ADMINISTRATION GRANTED ORPHAN DRUG DESIGNATION FOR LEAD MOLECULE PBT434 FOR TREATMENT OF MULTIPLE SYSTEM ATROPHY.  Full Article

Prana Biotechnology files for mixed shelf of upto $50 mln
Wednesday, 11 Oct 2017 

Oct 10 (Reuters) - Prana Biotechnology Ltd :Prana biotechnology ltd files for mixed shelf of upto $50 million - sec filing‍​.  Full Article